• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Damage similar in each eye after sequential ischemic optic neuropathy

byChaz Carrier
August 29, 2014
in Chronic Disease, Emergency, Ophthalmology
Reading Time: 2 mins read
Damage similar in each eye after sequential ischemic optic neuropathy
Share on FacebookShare on Twitter

1. The magnitude of retinal nerve fiber layer (RNFL) loss was similar in each eye following bilateral non-arteritic anterior ischemic optic neuropathy (NAION). 

2. Visual field loss was similar between the two eyes affected by NAION. 

Evidence Rating Level: 2 (Good)            

Study Rundown: Non-arteritic anterior ischemic optic neuropathy (NAION) occurs when there is loss of blood flow to the optic nerve. It is the most common form of ischemic optic neuropathy, typically causing sudden painless vision loss. Although simultaneous bilateral onset of NAION is extremely rare, sequential involvement of bilateral NAION frequently occurs among the elderly. In this study, the authors investigated whether structural damage and visual outcomes were similar in the two affected eyes following sequential involvement of bilateral NAION. They found that the magnitude of peripapillary RNFL loss was similar in each eye in patients who experienced bilateral NAION. In addition they found that visual outcomes, particularly visual field loss, was similar in the two eyes. An important strength of this study is the relatively high correlation coefficients (r=0.583, r=0.457). However, it is limited by its retrospective nature and small sample size. Although this study is not the first to delineate the correlation in structural damage and visual outcome following bilateral NAION, it reinforces previous findings.

Click to read the study in Current Eye Research

Relevant Reading: Optic Disc and Peripapillary Morphology in Unilateral Nonarteritic Anterior Ischemic Optic Neuropathy and Age- and Refraction-Matched Normals

RELATED REPORTS

The ONTT: Intravenous steroids lead to faster visual recovery in optic neuritis [Classics Series]

In-Depth [retrospective cohort]: This was a retrospective study involving 25 patients from two institutions. Patients were included if they had the diagnosis of NAION and had the sequential involvement of NAION in the contralateral eye. NAION was defined as sudden, painless vision loss initially accompanied by optic disc edema and splinter hemorrhages and later replaced by disc pallor. In this study, second eyes were affected by NAION about 3.4 years following the first episode. There were two significant findings: 1) a positive correlation between peripapillary RNFL thickness in the two affected eyes (r=0.583, p=0.002) and 2) a positive correlation between visual fields of the two affected eyes (r=0.457, p=0.042). Additionally, there was a weak, non-significant correlation in visual acuity between the eyes following NAION.

More from this author:  Comorbidities of head and neck cancer may drive malnutrition, One hour PTH levels may predict early post-thyroidectomy hypocalcemia, Similar outcomes with Kineflex-L and CHARITE lumbar total disc replacements 

Image: PD 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: optic neuropathy
Previous Post

Most cancer patients may not receive adequate treatment for comorbid depression

Next Post

Donor and recipient regulatory T-cells may promote transplant tolerance in mice

RelatedReports

Adverse pregnancy outcomes associated with thrombophilias [Classics Series]
Emergency Classics

The ONTT: Intravenous steroids lead to faster visual recovery in optic neuritis [Classics Series]

June 30, 2017
Next Post
Donor and recipient regulatory T-cells may promote transplant tolerance in mice

Donor and recipient regulatory T-cells may promote transplant tolerance in mice

Flexible sigmoidoscopy decreases colorectal cancer incidence and mortality

Lower colorectal cancer mortality after removal of low-risk adenomas

Large number of cancer patients in the US experience late hospice care

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • First messenger RNA influenza vaccine outperforms standard-dose vaccination
  • Few interventions improve posthospitalization follow-up for alcohol use disorder
  • Borderline-low hemoglobin levels linked to increased mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.